United States (US) Neuroblastoma Market (2025-2031) | Share, Competitive Landscape, Size & Revenue, Growth, Industry, Companies, Analysis, Trends, Value, Outlook, Segmentation, Forecast

Name: United States (US) Neuroblastoma Market (2025-2031) | Share & Competitive Landscape
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Diagnostics (MIBG scan, Imaging, Biopsy), By Treatment (Surgery, Medications, Chemotherapy, Radiation therapy, Stem cell transplant, Immunotherapy, Monoclonal antibody), By End-User (Hospitals and clinics, Ambulatory surgical centers, Diagnostic centers, Research centers, Others) And Competitive Landscape

Product Code: ETC9971351	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Neuroblastoma Market Outlook
Market Size of United States (US) Neuroblastoma Market, 2024
Forecast of United States (US) Neuroblastoma Market, 2031
Historical Data and Forecast of United States (US) Neuroblastoma Revenues & Volume for the Period 2021- 2031
United States (US) Neuroblastoma Market Trend Evolution
United States (US) Neuroblastoma Market Drivers and Challenges
United States (US) Neuroblastoma Price Trends
United States (US) Neuroblastoma Porter's Five Forces
United States (US) Neuroblastoma Industry Life Cycle
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Diagnostics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By MIBG scan for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Imaging for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Biopsy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Treatment for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Surgery for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Medications for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Chemotherapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Radiation therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Stem cell transplant for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Immunotherapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Monoclonal antibody for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By End-User for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Hospitals and clinics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Ambulatory surgical centers for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Diagnostic centers for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Research centers for the Period 2021- 2031
Historical Data and Forecast of United States (US) Neuroblastoma Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Neuroblastoma Import Export Trade Statistics
Market Opportunity Assessment By Diagnostics
Market Opportunity Assessment By Treatment
Market Opportunity Assessment By End-User
United States (US) Neuroblastoma Top Companies Market Share
United States (US) Neuroblastoma Competitive Benchmarking By Technical and Operational Parameters
United States (US) Neuroblastoma Company Profiles
United States (US) Neuroblastoma Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Neuroblastoma Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Neuroblastoma Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Neuroblastoma Market - Industry Life Cycle

3.4 United States (US) Neuroblastoma Market - Porter's Five Forces

3.5 United States (US) Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F

3.6 United States (US) Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F

3.7 United States (US) Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F

4 United States (US) Neuroblastoma Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Technological advancements in neuroblastoma treatment options

4.2.2 Increasing prevalence of neuroblastoma cases in the United States

4.2.3 Growing investments in research and development for neuroblastoma therapies

4.3 Market Restraints

4.3.1 High cost associated with neuroblastoma treatment and care

4.3.2 Stringent regulatory requirements for drug approvals in the neuroblastoma market

4.3.3 Limited awareness about neuroblastoma among the general population

5 United States (US) Neuroblastoma Market Trends

6 United States (US) Neuroblastoma Market, By Types

6.1 United States (US) Neuroblastoma Market, By Diagnostics

6.1.1 Overview and Analysis

6.1.2 United States (US) Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F

6.1.3 United States (US) Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F

6.1.4 United States (US) Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F

6.1.5 United States (US) Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F

6.2 United States (US) Neuroblastoma Market, By Treatment

6.2.1 Overview and Analysis

6.2.2 United States (US) Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F

6.2.3 United States (US) Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F

6.2.4 United States (US) Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F

6.2.5 United States (US) Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F

6.2.6 United States (US) Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F

6.2.7 United States (US) Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F

6.3 United States (US) Neuroblastoma Market, By End-User

6.3.1 Overview and Analysis

6.3.2 United States (US) Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F

6.3.3 United States (US) Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F

6.3.4 United States (US) Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F

6.3.5 United States (US) Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F

6.3.6 United States (US) Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Neuroblastoma Market Import-Export Trade Statistics

7.1 United States (US) Neuroblastoma Market Export to Major Countries

7.2 United States (US) Neuroblastoma Market Imports from Major Countries

8 United States (US) Neuroblastoma Market Key Performance Indicators

8.1 Patient survival rates post-treatment

8.2 Adoption rate of emerging neuroblastoma therapies

8.3 Number of clinical trials for neuroblastoma treatments

8.4 Patient quality of life improvements post-treatment

8.5 Availability and accessibility of support services for neuroblastoma patients and their families

9 United States (US) Neuroblastoma Market - Opportunity Assessment

9.1 United States (US) Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F

9.2 United States (US) Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F

9.3 United States (US) Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F

10 United States (US) Neuroblastoma Market - Competitive Landscape

10.1 United States (US) Neuroblastoma Market Revenue Share, By Companies, 2024

10.2 United States (US) Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Neuroblastoma Market

Eritrea Neuroblastoma Market

Estonia Neuroblastoma Market

Ethiopia Neuroblastoma Market

Finland Neuroblastoma Market

Gabon Neuroblastoma Market

Global Neuroblastoma Market

Middle East Neuroblastoma Market

North America Neuroblastoma Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here